Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin).
about
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitusThe New Era of Drug Therapy for Obesity: The Evidence and the ExpectationsDoes orlistat cause acute kidney injury?Orlistat--a novel weight loss therapy.Pharmacological treatment of obesity in children and adolescents: present and futureThe role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agentsOrlistat use in type 2 diabetes.Anti-Obesity Effects of Melastoma malabathricum var Alba Linn in Rats Fed with a High-Fat DietAnti-hyperlipidemic effect of soybean extract fermented by Bacillus subtilis MORI in db/db mice.Obesity management: what brings success?Intestinal removal of free fatty acids from hosts by Lactobacilli for the treatment of obesity.Can neuropeptides treat obesity? A review of neuropeptides and their potential role in the treatment of obesity.Influence of dietary composition on the inhibition of fat absorption by orlistat.
P2860
Q24245173-7D813E13-AF33-4315-A814-D750B98F96C0Q26827555-FB2C1863-4C4E-48E5-B4E1-8A5DBCC8AC3BQ26996838-410C53D6-2EE6-4B38-9834-654C330B5E09Q34191297-FB7177E4-0739-4EF7-A627-1598E47F513AQ34442880-CE271D19-4838-471C-8EFC-1703FCBB2606Q34620531-1DBD0955-233F-4E31-AE30-1C56D42F1FF1Q34709845-D26E20B2-9BAF-4FA0-B8B3-BADC110A1ACCQ35649830-33D4889E-88E8-4912-BAF3-5A5276C2ADBDQ36076549-4F58799E-653F-48F6-A953-0A76C2786CB9Q36515607-96FA9BF9-B3AB-4448-9798-711DA8FEE940Q36694416-0339B68E-D91D-44B2-858E-1B82F22369BBQ37337828-107F750D-49E3-4F0C-A36D-A2ED6CAFF8F0Q54024643-06D29BA1-AD5A-4326-A050-5C88C0489B7E
P2860
Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin).
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Initial studies in humans with ...... 18-0647 (tetrahydrolipstatin).
@ast
Initial studies in humans with ...... 18-0647 (tetrahydrolipstatin).
@en
type
label
Initial studies in humans with ...... 18-0647 (tetrahydrolipstatin).
@ast
Initial studies in humans with ...... 18-0647 (tetrahydrolipstatin).
@en
prefLabel
Initial studies in humans with ...... 18-0647 (tetrahydrolipstatin).
@ast
Initial studies in humans with ...... 18-0647 (tetrahydrolipstatin).
@en
P2093
P356
P1476
Initial studies in humans with ...... 18-0647 (tetrahydrolipstatin).
@en
P2093
Hartmann D
Hauptman JB
P304
P356
10.1093/AJCN/55.1.309S
P407
P433
P577
1992-01-01T00:00:00Z